Notice NOT-TR-24-003 from the NIH Guide for Grants and Contracts

Notice NOT-TR-24-004 from the NIH Guide for Grants and Contracts

Notice NOT-TR-24-005 from the NIH Guide for Grants and Contracts

Notice NOT-TR-24-006 from the NIH Guide for Grants and Contracts

Salary of £29,842 to £32,315: Rothamsted Research: The Alan Turing Institute have funded a programme of work which will be delivered by members of the Intelligent.... Harpenden, Hertfordshire

Salary of £31,350 to £32,315: Rothamsted Research: The Alan Turing Institute have funded a programme of work which will be delivered by members of the Intelligent.... Harpenden, Hertfordshire

Funding Opportunity RFA-HD-25-008 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity announcement (NOFO) is to support and facilitate multidisciplinary research approaches for the development of novel nonsteroidal contraceptive products for men and women that act prior to fertilization. This NOFO aims to position innovative and validated methods for future clinical development.

Notice NOT-NR-24-001 from the NIH Guide for Grants and Contracts

Notice NOT-AI-23-075 from the NIH Guide for Grants and Contracts

Notice NOT-DE-24-006 from the NIH Guide for Grants and Contracts

Notice NOT-MD-23-021 from the NIH Guide for Grants and Contracts

Notice NOT-AG-23-069 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-23-043 from the NIH Guide for Grants and Contracts. Through this non-competitive single source cooperative agreement Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits an application from (-----institute name-----) with the intent of funding a single award to continue to support the AIDS and Cancer Specimen Resource (ACSR). This is a reissue of RFA-CA-18-012. The ACSRs mission is to address the specimen needs of clinician and basic researchers in HIV and HIV-associated malignancy research. The ACSR is an international repository with specimens that reflect different eras of the epidemic (notably pre-cART and post-cART), different regions of the world, and people of diverse genetic backgrounds with different environmental exposures. Specimens have been obtained from people with HIV (PWH), people at risk for acquiring HIV, and HIV-uninfected controls. Specimens have been obtained from participants in clinical trials, observational cohort studies, or other research studies conducted by HIV investigators and consortium. The ACSR uses informed approaches to prospectively curate specimens in the USA, sub-Saharan Africa and Latin America that will be most valuable for the research community. Specimens and associated data are made available to the research community-at-large at NO COST. A second key role of the ACSR, is to serve as the AMC Biorepository for the AIDS Malignancy Consortium (AMC). The AMC is an NCI funded, multicenter clinical trials cooperative group that performs clinical trials research in the treatment and prevention of HIV-associated malignancies. The ACSR is currently providing support for domestic (two), sub-Saharan African, and Latin American biorepositories for the AMC.

Funding Opportunity PAR-24-043 from the NIH Guide for Grants and Contracts. Reissue of PAR-18-546. The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in medicinal chemistry, pharmacokinetics, toxicology, formulations development, chemical synthesis including under Good Manufacturing Practices (GMP), and Phase I clinical testing. Projects can enter either at the Discovery stage, to optimize promising hit compounds through medicinal chemistry to the Development stage, to advance a single development candidate through Investigational New Drug (IND)-enabling toxicology studies and phase I clinical testing. Alternatively, projects can enter at the Development stage and progress in a shorter period to IND enabling toxicology studies and phase I clinical testing. BPN awardee Institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN contractors (and thereby control the patent prosecution and licensing negotiations) for drug candidates developed in this program.

The Stewart laboratory is recruiting a postdoctoral researcher to develop novel computational data analysis tools and apply them to large biomedical datasets.
From Morgridge Institute for Research - Thu, 02 Nov 2023 02:06:15 GMT - View all Madison, WI jobs

F. Hoffmann-La Roche AG: Impact Healthcare Roche Diagnostics Cape Town is a dynamic and rapidly growing biotechnology organization employing cutting edge technologies to pr... South Africa

Exact Sciences: Position Overview The Senior Bioinformatics QA Engineer will play a pivotal role in ensuring the quality and reliability of our bioinformatics soft... San Diego, California

Preference will be given to those with a Master’s degree in microbiology, molecular biology, pre-veterinary science, biology, zoology, or another closely… $33 an hour
From State of Wyoming - Wed, 01 Nov 2023 20:50:55 GMT - View all Laramie, WY jobs

They will further partner with bioinformatics and computational team members to facilitate data analysis and interpretation. Receive results and compile data. $40,000 a year
From University of Wisconsin–Madison - Wed, 01 Nov 2023 18:57:31 GMT - View all Madison, WI jobs

Expenses-paid trip. Opportunity to win cash prizes.: Merck KGaA: If you are a post-graduate student with an interest in the specialty chemistry and pharmaceutical industries, the Innovation Cup... near Frankfurt, Germany